UP!
 |
|
|
Type
|
Public company |
|---|---|
| Traded as | NYSE: PHM S&P 500 Index component |
| Industry | Home construction |
| Founded | 1950 (1950) |
| Founder | Bill Pulte |
| Headquarters | Atlanta, Georgia |
|
Key people
|
Ryan R. Marshall, CEO & President G. Robert T. O'Shaughnessy, CFO |
|
Production output
|
19,951 new home deliveries |
| Revenue |  $7.668 billion (2016) |
|
Net income
|
$0.602 billion (2016) |
| Total assets | $10.178 billion (2016) |
| Total equity | 4.659 billion (2016) |
|
Number of employees
|
8,335 (2016) |
| Website | www |
PulteGroup, Inc. is a home construction company based in Atlanta, Georgia. In 2016, the company was the 3rd largest home construction company in the United States based on the number of homes closed. The company is ranked 353rd on the Fortune 500. The company operates in 49 markets in 25 states.
In 1950, when he was 18 years old, Bill Pulte began building and selling houses. In 1956, the company was formed.
In 1972, the company became a public company via an initial public offering.
In 1998, the company acquired Divosta for an estimated $150 million. The company also acquired Radnor Homes.
In 2001, the company acquired the Del E. Webb Construction Company, founded by Del Webb, for $1.8 billion.
In 2003, the company acquired Sivage-Thomas Homes.
In 2009, the company acquired Centex for $1.3 billion in stock.
In May 2013, the company moved its headquarters to Atlanta.
In August 2014, the company acquired the real estate assets of Dominion Homes for $82 million.
In January 2016, the company acquired certain assets of John Wieland Homes and Neighborhoods for $430.5 million in cash.
In September 2016, Ryan Marshall was appointed CEO, replacing Richard Dugas Jr., who was retiring.
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-24 | Future report Set alerts | |
| Q2 2022 | 2022-07-26 | 2.73 | 2.73 |
| Q1 2022 | 2022-04-28 | 1.83 | 1.83 |
| Q4 2021 | 2022-02-01 | 2.51 | 2.51 |
| Q3 2021 | 2021-10-26 | 1.82 | 1.82 |
| Q2 2021 | 2021-07-27 | 1.72 | 1.72 |
| Q1 2021 | 2021-04-27 | 1.28 | 1.28 |
| Q4 2020 | 2021-01-28 | 1.62 | 1.62 |
| Q3 2020 | 2020-10-22 | 1.54 | 1.54 |
| Q2 2020 | 2020-07-23 | 1.29 | 1.29 |
| 2016-07-06 | Reiterated Rating | Credit Suisse Group AG | Underperform | |
| 2016-06-28 | Reiterated Rating | Credit Suisse Group AG | Sell | |
| 2016-06-08 | Reiterated Rating | MKM Partners | Hold | |
| 2016-06-08 | Reiterated Rating | Deutsche Bank | Hold | |
| 2016-06-08 | Reiterated Rating | Deutsche Bank AG | Hold | |
| 2016-04-25 | Downgrade | Raymond James | Outperform to Market Perform | $19.00 |
| 2016-04-25 | Downgrade | Raymond James Financial Inc. | Outperform to Market Perform | $19.00 |
| 2016-04-23 | Reiterated Rating | FBR & Co. | Hold | $18.00 to $20.00 |
| 2016-04-23 | Reiterated Rating | Barclays | Hold | |
| 2016-04-23 | Reiterated Rating | FBR & Co | Hold | $18.00 to $20.00 |
| 2016-04-23 | Reiterated Rating | Barclays PLC | Hold | |
| 2016-04-22 | Boost Price Target | Barclays | Equal Weight | $18.00 to $20.00 |
| 2016-04-22 | Boost Price Target | RBC Capital | Outperform | $21.00 to $22.00 |
| 2016-04-22 | Boost Price Target | FBR & Co. | Mkt Perform | $18.00 to $20.00 |
| 2016-04-22 | Boost Price Target | Royal Bank Of Canada | Outperform | $21.00 to $22.00 |
| 2016-04-17 | Reiterated Rating | Deutsche Bank | Hold | |
| 2016-04-13 | Initiated Coverage | Cleveland Research | Neutral | |
| 2016-04-06 | Upgrade | Barclays | Underweight to Equal Weight | $18.00 |
| 2016-04-05 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $21.50 to $18.00 |
| 2016-04-04 | Downgrade | Zelman & Associates | Buy to Hold | |
| 2016-03-16 | Downgrade | Bank of America | Neutral to Underperform | $18.00 |
| 2016-03-16 | Downgrade | Bank of America Corp. | Neutral to Underperform | $18.00 |
| 2016-03-14 | Boost Price Target | RBC Capital | Outperform | $18.00 to $21.00 |
| 2016-01-31 | Reiterated Rating | FBR & Co. | Hold | |
| 2016-01-29 | Lower Price Target | FBR & Co. | Market Perform | $20.00 to $18.00 |
| 2016-01-29 | Boost Price Target | Barclays | $16.00 to $18.00 | |
| 2016-01-27 | Lower Price Target | RBC Capital | Outperform | $20.00 to $18.00 |
| 2016-01-20 | Lower Price Target | Barclays | Underweight | $18.00 to $16.00 |
| 2016-01-13 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $24.00 to $22.50 |
| 2016-01-08 | Upgrade | Raymond James | Market Perform to Outperform | $16.22 to $19.00 |
| 2015-12-22 | Downgrade | Sterne Agee CRT | Buy to Neutral | $18.00 |
| 2015-12-16 | Lower Price Target | RBC Capital | Outperform | $21.00 to $20.00 |
| 2015-12-16 | Reiterated Rating | Credit Suisse | Underperform | $16.00 |
| 2015-10-27 | Boost Price Target | S&P Equity Research | Buy | $20.00 to $22.00 |
| 2015-10-23 | Lower Price Target | RBC Capital | Outperform | $24.00 to $21.00 |
| 2015-10-23 | Lower Price Target | Citigroup Inc. | $22.00 to $20.00 | |
| 2015-10-23 | Reiterated Rating | Barclays | Underweight | $17.00 to $18.00 |
| 2015-10-23 | Boost Price Target | FBR & Co. | Market Perform | $20.00 to $22.00 |
| 2015-10-22 | Reiterated Rating | Compass Point | Neutral | $21.00 |
| 2015-10-15 | Lower Price Target | Mackie | Buy | C$2.50 to C$1.25 |
| 2015-10-14 | Reiterated Rating | Barclays | Sell | |
| 2015-10-13 | Lower Price Target | Barclays | Underweight | $19.00 to $17.00 |
| 2015-10-13 | Downgrade | Morgan Stanley | Equal Weight to Underweight | $22.00 to $18.00 |
| 2015-09-11 | Reiterated Rating | Bank of America | Hold | |
| 2015-09-11 | Upgrade | JPMorgan Chase & Co. | Underweight to Neutral | $19.00 to $23.50 |
| 2015-05-23 | Reiterated Rating | Sterne Agee CRT | Buy | |
| 2015-05-15 | Downgrade | Raymond James | Outperform to Market Perform | |
| 2015-04-24 | Reiterated Rating | Barclays | Underweight | $17.00 to $18.00 |
| 2015-04-24 | Upgrade | Zelman & Associates | Hold to Buy | |
| 2015-04-09 | Downgrade | JPMorgan Chase & Co. | Neutral to Underweight | $21.00 |
| 2015-03-09 | Upgrade | Buckingham Research | Neutral to Buy | |
| 2015-01-30 | Boost Price Target | Citigroup Inc. | Neutral | $20.00 to $22.00 |
| 2015-01-30 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | $22.00 to $21.00 |
| 2015-01-30 | Downgrade | Wells Fargo | Outperform to Market Perform | $22.00 to $21.00 |
| 2015-01-29 | Boost Price Target | Compass Point | Neutral | $19.00 to $21.00 |
| 2015-01-20 | Downgrade | Buckingham Research | Buy to Neutral | $24.00 to $23.00 |
| 2015-01-20 | Downgrade | Credit Suisse | Neutral to Underperform | $20.00 to $19.00 |
| 2015-01-15 | Initiated Coverage | Morgan Stanley | Equal Weight | $24.00 |
| 2015-01-12 | Boost Price Target | JPMorgan Chase & Co. | Neutral | $22.00 to $23.00 |
| 2014-12-10 | Reiterated Rating | RBC Capital | Outperform | $24.00 |
| 2014-12-10 | Boost Price Target | Susquehanna | Positive | $23.00 to $26.00 |
| 2014-11-10 | Upgrade | Bank of America | Neutral to Buy | $23.00 to $25.00 |
| 2014-10-24 | Boost Price Target | RBC Capital | Outperform | $19.00 to $22.00 |
| 2014-10-20 | Initiated Coverage | Buckingham Research | Buy | $24.00 |
| 2014-10-13 | Reiterated Rating | Barclays | Underweight | $22.00 to $19.00 |
| 2014-10-13 | Reiterated Rating | Compass Point | Neutral | $18.00 to $19.00 |
| 2014-10-10 | Upgrade | FBN Securities | Underperform to Sector Perform | |
| 2014-10-01 | Upgrade | Goldman Sachs | Sell to Neutral | $18.50 |
| 2014-10-01 | Upgrade | Goldman Sachs Group Inc. | Sell to Neutral | $18.50 |
| 2014-09-15 | Reiterated Rating | S&P Equity Research | Buy | |
| 2014-09-09 | Upgrade | JPMorgan Chase & Co. | Underweight to Neutral | $19.00 to $22.00 |
| 2014-09-02 | Downgrade | FBR & Co. | Outperform to Market Perform | $22.00 |
| 2014-07-25 | Lower Price Target | FBR & Co. | Outperform | $24.00 to $22.00 |
| 2014-06-30 | Boost Price Target | Barclays | Underweight | $20.00 to $22.00 |
| 2014-03-25 | Downgrade | Barclays | Equal Weight to Underweight | $21.00 to $20.00 |
| 2014-03-12 | Downgrade | Credit Suisse | Outperform to Neutral | $20.00 |
| 2014-03-04 | Upgrade | KeyBanc | Hold to Buy | $26.00 |
| 2014-02-03 | Upgrade | Susquehanna | Neutral to Positive | $19.00 to $25.00 |
| 2014-01-31 | Boost Price Target | FBR & Co. | Outperform | $22.00 to $24.00 |
| 2014-01-31 | Upgrade | Raymond James | Market Perform to Outperform | $23.00 |
| 2014-01-27 | Boost Price Target | Barclays | Equal Weight | $19.00 to $20.00 |
| 2014-01-10 | Downgrade | JPMorgan Chase & Co. | Neutral to Underweight | $18.00 |
| 2014-01-09 | Boost Price Target | MKM Partners | Neutral | $19.00 to $21.00 |
| 2013-12-30 | Downgrade | FBN Securities | Sector Perform to Underperform | |
| 2013-11-22 | Boost Price Target | RBC Capital | $20.00 to $21.00 | |
| 2013-10-24 | Reiterated Rating | MKM Partners | Neutral | $16.00 to $19.00 |
| 2013-10-11 | Reiterated Rating | Susquehanna | Neutral | $15.00 to $17.00 |
| 2016-07-06 | Reiterated Rating | Credit Suisse Group AG | Underperform | |
| 2016-06-28 | Reiterated Rating | Credit Suisse Group AG | Sell | |
| 2016-06-08 | Reiterated Rating | MKM Partners | Hold | |
| 2016-06-08 | Reiterated Rating | Deutsche Bank | Hold | |
| 2016-06-08 | Reiterated Rating | Deutsche Bank AG | Hold |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In PHM 457 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 27.47M |
| BlackRock Inc. | 21.24M |
| STATE STREET CORP | 10.71M |
| BlackRock Fund Advisors | 10.20M |
| BlackRock Institutional Trust Company, N.A. | 9.36M |
| PUTNAM INVESTMENTS LLC | 9.18M |
| DIMENSIONAL FUND ADVISORS LP | 6.67M |
| HARRIS ASSOCIATES L P | 5.95M |
| ALLIANCEBERNSTEIN L.P. | 5.71M |
| GREENHAVEN ASSOCIATES INC | 5.62M |
| GEODE CAPITAL MANAGEMENT, LLC | 5.46M |
| LSV ASSET MANAGEMENT | 4.94M |
| CITY NATIONAL BANK | 4.57M |
| FIRST TRUST ADVISORS LP | 4.54M |
| AMERIPRISE FINANCIAL INC | 4.01M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| DUGAS RICHARD J JR Pres. and Chief Exec. Officer | 0.28% (1049927) | PHM / |
| MARSHALL RYAN Area President | 0.09% (347362) | PHM / |
| OShaughnessy Robert Exec. VP & CFO | 0.09% (346963) | PHM / |
| SMITH HARMON D Area President | 0.08% (309584) | PHM / |
| COOK STEVEN M SVP, Gen Counsel & Secretary | 0.07% (263495) | PHM / |
| Ellinghausen James R Exec. Vice President-HR | 0.05% (199981) | PHM / |
| CHADWICK JOHN JAMES Area President | 0.04% (161097) | PHM / |
| BEIRNE PATRICK Area President | 0.03% (125549) | PCYO / PHM / |
| BLAIR BRYCE | 0.03% (114948) | PHM / REG / |
| POSTL JAMES J | 0.03% (113136) | PHM / |
| ANDERSON BRIAN P | 0.03% (101744) | CAS / GWW / PHM / SRCL / |
| KELLY ENNIS DEBRA J | 0.03% (100935) | CCL / CUK / HTZ / MO / PHM / |
| SCHLAGETER STEPHEN P Area President | 0.03% (98674) | PHM / |
| Meyer Deborah W. SVP & Chief Marketing Officer | 0.02% (89128) | PHM / |
| OLEARY PATRICK J | 0.02% (89010) | PHM / SPW / |
| Schweninger Michael John VP & Controller | 0.02% (77426) | PHM / |
| FOLLIARD THOMAS J | 0.02% (61527) | KMX / PHM / |
| Hawaux Andre J | 0.01% (44057) | DKS / PHM / |
| Sheldon Todd N EVP, Gen Counsel, Corp Sec\'y | 0.01% (44032) | PHM / SVU / |
| OSSOWSKI JAMES L VP Finance & Controller | 0.01% (38695) | PHM / |
UM